We serve Chemical Name:6-guanidinohexanoic acid CAS:6659-35-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-guanidinohexanoic acid
CAS.NO:6659-35-4
Synonyms:6-Guanidino-hexansaeure;guanidinohexanoic acid;6-carbamimidamidohexanoic acid;6-Guanidinohexanoic acid;6-Guanidinocaproic acid
Molecular Formula:C7H15N3O2
Molecular Weight:173.21300
HS Code:2925290090
Physical and Chemical Properties:
Melting point:-310ºC
Boiling point:385.2ºC at 760 mmHg
Density:1.25 g/cm3
Index of Refraction:1.541
PSA:99.20000
Exact Mass:173.11600
LogP:1.30540
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 6-Guanidino-hexansaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Guanidinocaproic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-carbamimidamidohexanoic acid Use and application,6-Guanidinocaproic acid technical grade,usp/ep/jp grade.
Related News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. N-(2-Amino-aethyl)-4-brom-N-dichlorjod-naphthalsaeure-1-amid manufacturers “The jury was careful and awarded us what we’d asked for down to the penny,” Plexxikon’s lawyer Daralyn Durie told Bloomberg after the verdict came down. trisodium,hydron,3,5,5-trimethyl-N,N-bis(phosphonatomethyl)hexan-1-amine suppliers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. Tris{N-[(1-ethyl-2-pyrrolidinyl)methyl](3-methoxy-1-benzothiophen -2-yl)oxomethanaminium} phosphate vendor & factory.
